MX2018013808A - Metodo analitico para cuantificacion de bacterias viables contenidas en composiciones para terapia de restauracion de microbiota (mrt). - Google Patents

Metodo analitico para cuantificacion de bacterias viables contenidas en composiciones para terapia de restauracion de microbiota (mrt).

Info

Publication number
MX2018013808A
MX2018013808A MX2018013808A MX2018013808A MX2018013808A MX 2018013808 A MX2018013808 A MX 2018013808A MX 2018013808 A MX2018013808 A MX 2018013808A MX 2018013808 A MX2018013808 A MX 2018013808A MX 2018013808 A MX2018013808 A MX 2018013808A
Authority
MX
Mexico
Prior art keywords
viable bacteria
quanitification
mrt
compositions
analytical method
Prior art date
Application number
MX2018013808A
Other languages
English (en)
Inventor
ERICKSON Joshua
Burroughs Maya
Sinclair Ian
R Jones Courtney
Anne- Szkudlarek Brown Beth
Original Assignee
Rebiotix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rebiotix Inc filed Critical Rebiotix Inc
Publication of MX2018013808A publication Critical patent/MX2018013808A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06Quantitative determination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/125Specific component of sample, medium or buffer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00Reactions characterised by their quantitative nature
    • C12Q2545/10Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/113Reactions characterised by their quantitative nature the purpose being quantitative analysis with an external standard/control, i.e. control reaction is separated from the test/target reaction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor

Abstract

Cuantificación de los microorganismos bacterianos viables en un producto de fármaco para el suministro por la vía de un tubo gastro-nasal, un enema y/o una cápsula o tableta. Un procedimiento de base molecular, tal como los ensayos de PMA (monazida de propidio)-qPCR (reacción en cadena de polimerasa cuantitativa) puede ser útil para la cuantificación de bacterias viables. Al utilizar el tratamiento de PMA en combinación con qPCR, se puede determinar el número de células bacterianas viables en la muestra.
MX2018013808A 2016-05-13 2017-05-12 Metodo analitico para cuantificacion de bacterias viables contenidas en composiciones para terapia de restauracion de microbiota (mrt). MX2018013808A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662336184P 2016-05-13 2016-05-13
PCT/US2017/032555 WO2017197364A1 (en) 2016-05-13 2017-05-12 Analytical method for quanitification of viable bacteria contained in microbiota restoration therapy (mrt) compositions

Publications (1)

Publication Number Publication Date
MX2018013808A true MX2018013808A (es) 2019-03-28

Family

ID=58765992

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013808A MX2018013808A (es) 2016-05-13 2017-05-12 Metodo analitico para cuantificacion de bacterias viables contenidas en composiciones para terapia de restauracion de microbiota (mrt).

Country Status (12)

Country Link
US (1) US20170327862A1 (es)
EP (1) EP3455373A1 (es)
JP (1) JP2019520804A (es)
KR (1) KR20190003996A (es)
CN (1) CN109415760A (es)
AU (1) AU2017261820B2 (es)
BR (1) BR112018073330A2 (es)
CA (1) CA3022847A1 (es)
IL (1) IL262847A (es)
MX (1) MX2018013808A (es)
RU (2) RU2020106956A (es)
WO (1) WO2017197364A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018187272A1 (en) 2017-04-03 2018-10-11 Gusto Global, Llc Rational design of microbial-based biotherapeutics
WO2019213595A1 (en) 2018-05-04 2019-11-07 Ferring B.V. Microbiota restoration therapy (mrt) compositions and methods of manufacture
WO2019241523A1 (en) 2018-06-14 2019-12-19 Rebiotix, Inc. Microbiota restoration therapy (mrt) compositions and methods of manufacture
CN109811040A (zh) * 2019-02-21 2019-05-28 北京农业智能装备技术研究中心 一种基于pma染色的病菌定量检测方法
WO2020218557A1 (ja) * 2019-04-26 2020-10-29 bitBiome株式会社 単一生物単位の生菌由来核酸の選択的検出、カウント、ゲノム解析
WO2022051610A1 (en) 2020-09-04 2022-03-10 Ferring B.V. Microbiota restoration therapy (mrt) compositions and methods of manufacture

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6330032B2 (ja) 2013-06-05 2018-05-23 レビオティクス インコーポレイテッドRebiotix,Inc. 微生物叢回復療法組成物を製造、処理、および梱包するための方法

Also Published As

Publication number Publication date
RU2714841C1 (ru) 2020-02-19
US20170327862A1 (en) 2017-11-16
WO2017197364A1 (en) 2017-11-16
AU2017261820A1 (en) 2018-11-22
JP2019520804A (ja) 2019-07-25
CN109415760A (zh) 2019-03-01
BR112018073330A2 (pt) 2019-02-26
EP3455373A1 (en) 2019-03-20
RU2020106956A (ru) 2020-08-13
CA3022847A1 (en) 2017-11-16
KR20190003996A (ko) 2019-01-10
AU2017261820B2 (en) 2021-02-18
IL262847A (en) 2018-12-31

Similar Documents

Publication Publication Date Title
MX2018013808A (es) Metodo analitico para cuantificacion de bacterias viables contenidas en composiciones para terapia de restauracion de microbiota (mrt).
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
MX2017010710A (es) Composición terapeútica y profiláctica producida por microbiota.
ECSP14024082A (es) Material no viable derivado de probióticos para la prevención y tratamiento de infecciones
MX2016012891A (es) Uso de bacterias, productos bacterianos, y otras entidades inmunorreguladoras en combinacion con anticuerpos anti antigeno 4 de linfocitos t citotoxicos (ctla-4) y/o anti proteina 1 de muerte celular programada (pd-1) para tratar neoplasias de tumor solido.
WO2015031441A3 (en) Microorganisms engineered to use unconventional sources of phosphorus or sulfur
EA201692258A1 (ru) Композиция и способ для стабилизации и поддержания жизнеспособности устойчивых микроорганизмов
MX2020006865A (es) Composiciones y metodos de extraccion, respetuosos con el medio ambiente, de minerales y metales de la mena.
MX2017011277A (es) Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades.
WO2016012459A3 (en) Parallel cell processing method and facility
AU2016206832A8 (en) Non-invasive systems and methods for treatment of a host carrying a virus with photoactivatable drugs
EP4252742A3 (en) Fluticasone furoate in the treatment of copd
NZ731398A (en) Noscapinoid-producing microbes and methods of making and using the same
WO2017218922A8 (en) Compositions and methods for the treatment of bacterial infections
MX2020005245A (es) Metodos de pcr asimetrica.
WO2014153567A3 (en) Inhibition of methane production during anaerobic reductive dechlorination
MX2022003399A (es) Metodo basado en celulas para determinar la potencia de la defibrotida.
CL2020001358A1 (es) Cepa vacunal de brucella modificada para el tratamiento de brucelosis
MX371363B (es) Metodos de deteccion y cuantificacion de bacterias contenidas en o dentro de goma de mascar.
WO2018175296A3 (en) Programmable nucleic acid synthesis cascade
MD228Z (ro) Procedeu de cultivare a cianobacteriei Spirulina platensis
MY176569A (en) Method of removing dna from biotechnological products
MX2017000118A (es) Biocontrol de enfermedades asociadas a la semilla en plantulas.
MD4492C1 (ro) Procedeu de cultivare a cianobacteriei Spirulina platensis
UA98472U (ru) Способ детекции dirofilaria imitis и dirofilaria repens в биологических образцах с помощью полимеразной цепной реакции